Vishwas Seshadri - Jun 1, 2021 Form 4 Insider Report for ABEONA THERAPEUTICS INC. (ABEO)

Role
SVP, Head of Res./Clin. Dev.
Signature
/s/ Vishwas Seshadri
Stock symbol
ABEO
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4
Date filed
6/3/2021, 09:06 PM
Next filing
Oct 18, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABEO Common stock Award $0 +200K $0.00 200K Jun 1, 2021 Direct F1
transaction ABEO Common stock Award $0 +100K +50% $0.00 300K Jun 1, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABEO Stock Option (right to buy) Award $0 +400K $0.00 400K Jun 1, 2021 Common Stock 400K $1.71 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock will vest 25% on each of June 1, 2022, June 1, 2023, June 1, 2024 and June 1, 2025.
F2 The restricted stock will vest 100% on each of June 1, 2022.
F3 The options will vest 25% on June 1, 2022, and in 36 equal monthly installments thereafter.